Skip to main content

Venkatadri Bobba

Cancer Genetics has added Venkatadri Bobba to Cancer Genetics India's board of directors. Bobba has more than 36 years of leadership experience in the pharmaceutical and life sciences industries and is currently a general partner with Ventureast. Previously, he was senior vice president of operations at Aradigm, and between 2001 and 2003 he was executive VP at Diosynth.  

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.